The Clinical trials acknowledging the ERN-EuroBloodNet that involve ERN Members and Affiliated partners in at least two Member States are listed below.
| Monitoring period | Title | Members and Affiliated Partners | Member State(s) |
|---|---|---|---|
| 2022 | Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic Syndrome (SINTRA-REV) | Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Universitätsklinikum Carl Gustav Carus and Hospital Universitario Virgen del Rocío | France, Germany and Spain |
